Nódulos tiroideos benignos

1. Davies L, Ouellette M, Hunter M, Welch HG. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope. 2010;120(12):2446-2451.
2. Sosa JA, Hanna JW, Robinson KA, Lanman RB. Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. Surgery. 2013;154(6):1420-1426.
3. Smith-Bindman R, Lebda P, Feldstein VA, et al. Risk of thyroid cancer based on thyroid ultrasound imaging characteristics: results of a population-based study.JAMA Intern Med. 2013;173(19):1788-1796.
4. Papini E, Guglielmi R, Bianchini A, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.J Clin Endocrinol Metab. 2002;87(5): 1941-1946.
5. Mandel SJ. Diagnostic use of ultrasonography in patients with nodular thyroid disease. Endocr Pract. 2004;10(3):246-252.
6. Gharib H, Papini E, Paschke R, et al; AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and EuropeanThyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2010;16(suppl 1):1-43.
7. Cooper DS, Doherty GM, Haugen BR, et al; American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167-1214.
8. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154(6):787-803.
9. Filetti S, Durante C, Torlontano M. Nonsurgical approaches to the management of thyroid nodules. Nat Clin Pract Endocrinol Metab. 2006;2(7):384-394.
10. Knudsen N, Bols B, Bülow I, et al. Validation of ultrasonography of the thyroid gland for epidemiological purposes. Thyroid. 1999;9(11): 1069-1074.
11. Brauer VF, Eder P, Miehle K, Wiesner TD, Hasenclever H, Paschke R. Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid. 2005;15(10):1169-1175.
12. Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997;16 (20):2349-2380.
13. Ciampi A. Constructing Prediction Trees From Data: The RECPAM Approach Proceedings From the Prague 1991 Summer School on Computational Aspects of Model Choice. Heidelberg, Germany: Physica-Verlag; 1992:165-178.
14. Franciosi M, Pellegrini F, De Berardis G, et al; QuED Study Group—Quality of Care and Outcomes in Type 2 Diabetes. Self-monitoring of blood glucose in non–insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med. 2005;22(7):900-906.
15. Anil C, Akkurt A, Ayturk S, Kut A, Gursoy A. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism. 2013;62(7):970-975.
16. Sousa PA, Vaisman M, Carneiro JR, et al. Prevalence of goiter and thyroid nodular disease in patients with class III obesity. Arq Bras Endocrinol Metabol. 2013;57(2):120-125.
 17. Rendina D, De Filippo G, Mossetti G, et al. Relationship between metabolic syndrome and multinodular non-toxic goiter in an inpatient population from a geographic area with moderate iodine deficiency.J Endocrinol Invest. 2012;35(4): 407-412.
18. Brix TH, Hansen PS, Kyvik KO, Hegedüs L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case-control study. Arch Intern Med. 2000;160(5):661-666.
19. Quadbeck B, Pruellage J, Roggenbuck U, et al. Long-term follow-up of thyroid nodule growth. Exp Clin Endocrinol Diabetes. 2002;110(7):348-354.
20. Alexander EK, Hurwitz S, Heering JP, et al. Natural history of benign solid and cystic thyroid nodules. Ann Intern Med. 2003;138(4):315-318.
21. Erdogan MF, Gursoy A, Erdogan G. Natural course of benign thyroid nodules in a moderately iodine-deficient area. Clin Endocrinol (Oxf), 2006; 65(6):767-771.
22. Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology: current status. CA Cancer J Clin. 2009;59(2):99-110.
23. Nou E, Kwong N, Alexander LK, Cibas ES, Marqusee E, Alexander EK. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration.J Clin Endocrinol Metab. 2014;99(2):510-516.
24. Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34(1):28-35.
25. Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management.J Clin Endocrinol Metab. 2009;94(5): 1748-1751.
26. Aghini-Lombardi F, Vitti P, Antonangeli L, et al; Southern Italy Study Group for Iodine Deficiency Disorders. The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy.J Endocrinol Invest. 2013;36(5):282-286.
27. Watutantrige Fernando S, Barollo S, Nacamulli D, et al. Iodine status in schoolchildren living in northeast Italy: the importance of iodized-salt use and milk consumption. Eur J Clin Nutr. 2013;67(4): 366-370.
28. Cibas ES, Ali SZ; NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658-665.
29. Gharib H, Hegedüs L, Pacella CM, Baek JH, Papini E. Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013;98(10):3949-3957.